Triphase is driven by innovation and creativity, and strive towards developing newer, revolutionary products that help prevent and combat diseases. Triphase has a deep-rooted ambition of developing a scientific approach to enhancing the quality of human life. The company believes in proof of facts, with well documented clinical trials, to substantiate its claims. The company stands tall on the pillars of plausibility and certainty in its research.
Triphase mission is to place a high premium on respecting individual strengths and yet working as a team to accomplish the same. The company positions itself as an enterprise that exists “By nature (Probiotic products & its techniques), to nature (sustenance) and for nature (eco-friendly).”
A people-centric company, Triphase is World’s first and only Biotech Company making High Temperature Stable Probiotic strains for food, confectionary & dietary supplements”. With a vision to become a globally accomplished health and wellness R & D Organization and to improve Quality of Life, the team at Triphase comprises of agile Board of Directors, Advisory team and Management team and Interdisciplinary scientist. Triphase Pharmaceuticals Pvt. Ltd. is an enterprise where the domain of research focuses on robust scientific foundations. Maintaining sound health by well- established scientifically and clinically validated mechanisms that are naturally bestowed on human beings is the motto of the company.
Triphase was awarded a US PATENT for the technology by which Probiotics bacteria’s could withstand temperatures of up to 200++ degrees. This is the first time in the world that a disruptive platform innovation has been successfully completed . In one single stroke the company had eliminated any need for cold storage – a huge cost saving in probiotic industry.
Some of the high-demand products of the company include:
• Temperature Stable Probiotics
• Mineral Enriched Yeasts
Triphase Pharmaceuticals Private Limited is led by professionals and accomplished scientists from the biotech and food industries. The team at Triphase is qualified and believes in the fundamental of ‘Prevention is better than cure.’
• September 2019 – Speaker and panellist art SWEEP
• 2019 and FLNN -19 EMERG Forum
• August, 2019 – Speaker and panellist at WISE Mysore
• July , 2019 – Speaker and Panellist at Biotech forum Mysore
• April 2019 – JSS – Triphase collaboration partnership
• March 2019 – FKCCI – Women Achiever Award
• November 2018 – Conferred with Bio-Excellence Emerging Company Award 2018 by Government of Karnataka.
• October 2018 – Certificate of Achievement awarded to Dr. Shrilakshmi Desiraju, Founder and Director
(Business Development), M/s Triphase Pharmaceuticals at the International Conference on Probiotics and Prebiotics held at San Francisco, USA.
• August 2018 – 1 st US Patent Awarded in August 2018.
• December 2017 – Featured in Bio spectrum
• November 2017 – Nominated for INDIA 5000 best MSME award
• January – 2016 Winner of Economic Times-Power Of Ideas .
• 2015- Innovation excellence award from FKCCI (federation of Karnataka chambers of Commerce).
• 2014 – INDIAs Small Giant award for the most promising small and medium size company.
• 2014 – Business women of the year awarded by EMERG,
• October 2014– Provisional Patent Application filed & accepted and number assigned for proprietary technolgy.
• January 2015 – Temperature stable Lactobacillus strains deposited in American Type Culture Collection, Virginia.
The USA, and Strain accession number assigned as part of patenting Application.
• October 2015 – Filed e-PCT & Indian Patent on Temperature stable Lactobacillus strains.
• June 2016 – Filed US Patent on Temperature stable Lactobacillus strains.
• Sept – 2017 – Filed Canadian on Temperature stable Lactobacillus strains.
• August 2018 – US patent Awarded
• Sept 2019- ISO 9000:2015 Awarded
• An innovative and budding enterprise primarily believe in the prevailing scientific emphasis on Health and Wellness.
• Dedicated to research on probiotics and its inter-related are as in prebiotics, enzymes, and mineral
• Successfully developed some unique probiotic and related ingredients.
• The Company specializes in the development of high temperature stable probiotics and their application along two verticals (B2B and B2C).
• Galvanized by state of the art R&D center, Triphase has experienced scientists and technical
experts who steer their efforts towards the latest and the next generation of innovations as value-added ingredients.
Triphase was founded in 2009 by Shri Aditya Desiraju and Dr. Shrilakshmi Desiraju, whose farsighted vision is the present stature of Triphase. Dr. Shrilakshmi Desiraju started her journey of innovation with Triphase in the field of Probiotics in 2011. The first big challenge that Triphase solved was in eliminating the cold chain from the Probiotics industry.
Dr. Desiraju has been involved in the strategic planning and implementation of growth for her current organization. A state of art research and development wing for probiotic research at Mysore has been established since 2011.
Dr. Desiraju has an MBA degree in Technology Commercialization from University of Alberta, Canada, a Ph.D. degree in Medicinal Chemistry from the Vikram University Ujjain (M.P.), and post-doctoral experience from the Indian Institute of Science, Bengaluru. She has a strong publication record in both scientific and business publications and is the recipient of several international awards. Under the leadership of Dr. Desiraju, Triphase has successfully launched three prescription drugs in India since 2009 and US patented platform technology in North America.
Triphase also secured series A venture funding by a fortune 500 pharma company to develop robust R&D in the field of Probiotics. This funding has been made to enhance the Triphase proprietary temperature stable Probiotic platform.
Triphase recently got in collaboration to work with JSS Academy of Higher education and research for their preclinical and clinical research collaboration to bring cost effective pharma probiotic products with their JV partner in the market With a patented technology to its credit, Shrilakshmi Desiraju’s Triphase has made a significant dent in the pharma universe dominated by large corporations. Since its inception, Triphase has been instrumental in delivering conceptual solutions in the field of healthcare, an extremely sensitive need in India.
For More Details: https://www.triphasepharma.com/